These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23967339)

  • 21. Novel model of antigen-specific induction of bile duct injury.
    Buxbaum J; Qian P; Khuu C; Shneider BL; Daikh DI; Gershwin ME; Allen PM; Peters MG
    Gastroenterology; 2006 Dec; 131(6):1899-906. PubMed ID: 17087941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-infiltrating mast cells stimulate ICOS
    Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
    J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Myeloid Leukemia Cells Express ICOS Ligand to Promote the Expansion of Regulatory T Cells.
    Han Y; Dong Y; Yang Q; Xu W; Jiang S; Yu Z; Yu K; Zhang S
    Front Immunol; 2018; 9():2227. PubMed ID: 30319662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin regulates the differentiation of naïve CD4+T cells and activates IL-10 immune modulation against acute lung injury in mice.
    Chai YS; Chen YQ; Lin SH; Xie K; Wang CJ; Yang YZ; Xu F
    Biomed Pharmacother; 2020 May; 125():109946. PubMed ID: 32004976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vendor-specific microbiome controls both acute and chronic murine lung allograft rejection by altering CD4
    Guo Y; Wang Q; Li D; Onyema OO; Mei Z; Manafi A; Banerjee A; Mahgoub B; Stoler MH; Barker TH; Wilkes DS; Gelman AE; Kreisel D; Krupnick AS
    Am J Transplant; 2019 Oct; 19(10):2705-2718. PubMed ID: 31278849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4 T cell-dependent conditioning of dendritic cells to produce IL-12 results in CD8-mediated graft rejection and avoidance of tolerance.
    Filatenkov AA; Jacovetty EL; Fischer UB; Curtsinger JM; Mescher MF; Ingulli E
    J Immunol; 2005 Jun; 174(11):6909-17. PubMed ID: 15905533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
    Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
    J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation.
    Medoff BD; Seung E; Wain JC; Means TK; Campanella GS; Islam SA; Thomas SY; Ginns LC; Grabie N; Lichtman AH; Tager AM; Luster AD
    J Exp Med; 2005 Jul; 202(1):97-110. PubMed ID: 15998790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A direct comparison of rejection by CD8 and CD4 T cells in a transgenic model of allotransplantation.
    Porrett PM; Lee MK; Lian MM; Wang J; Caton AJ; Deng S; Markmann JF; Moore DJ
    Arch Immunol Ther Exp (Warsz); 2008; 56(3):193-200. PubMed ID: 18512028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.
    Metzger TC; Long H; Potluri S; Pertel T; Bailey-Bucktrout SL; Lin JC; Fu T; Sharma P; Allison JP; Feldman RM
    Cancer Res; 2016 Jul; 76(13):3684-9. PubMed ID: 27197182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ICOS regulates the generation and function of human CD4+ Treg in a CTLA-4 dependent manner.
    Zheng J; Chan PL; Liu Y; Qin G; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
    PLoS One; 2013; 8(12):e82203. PubMed ID: 24312642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo environment necessary to support transplanted donor mouse T regulatory cells.
    Cabello-Kindelan C; de la Barrera A; Malek TR; Bayer AL
    Am J Transplant; 2014 May; 14(5):1032-45. PubMed ID: 24618297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 15 and CD4⁺ T cells cooperate to promote small intestinal enteropathy in response to dietary antigen.
    Korneychuk N; Ramiro-Puig E; Ettersperger J; Schulthess J; Montcuquet N; Kiyono H; Meresse B; Cerf-Bensussan N
    Gastroenterology; 2014 Apr; 146(4):1017-27. PubMed ID: 24361466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation.
    Wiley RE; Goncharova S; Shea T; Johnson JR; Coyle AJ; Jordana M
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):722-30. PubMed ID: 12760969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.
    Lee HJ; Kim SN; Jeon MS; Yi T; Song SU
    Sci Rep; 2017 Mar; 7():44486. PubMed ID: 28290526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection.
    Redpath SA; van der Werf N; Cervera AM; MacDonald AS; Gray D; Maizels RM; Taylor MD
    Eur J Immunol; 2013 Mar; 43(3):705-15. PubMed ID: 23319295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
    Sim GC; Liu C; Wang E; Liu H; Creasy C; Dai Z; Overwijk WW; Roszik J; Marincola F; Hwu P; Grimm E; Radvanyi L
    Cancer Immunol Res; 2016 Nov; 4(11):983-994. PubMed ID: 27697858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.